TVRRX
Price
$92.22
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
495.26M
VIMAX
Price
$395.75
Change
+$3.54 (+0.90%)
Updated
Jun 2 closing price
Net Assets
213.76B
Interact to see
Advertisement

TVRRX vs VIMAX

Header iconTVRRX vs VIMAX Comparison
Open Charts TVRRX vs VIMAXBanner chart's image
TVRRX vs VIMAX Comparison Chart in %
View a ticker or compare two or three
VS
TVRRX vs. VIMAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TVRRX is a Hold and VIMAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 214B vs. TVRRX (495M). VIMAX pays higher dividends than TVRRX: VIMAX (1.36) vs TVRRX (0.00). TVRRX was incepted earlier than VIMAX: TVRRX (21 years) vs VIMAX (25 years). TVRRX (1.90) is less costly to investors than VIMAX (0.05). TVRRX is a more actively managed with annual turnover of: 23.05 vs. VIMAX (16.00). TVRRX has a lower initial minimum investment than VIMAX: TVRRX (0) vs VIMAX (3000). VIMAX (17.06) and TVRRX (16.87) have marching annual gain over last year. VIMAX return over 5 years is better than : 36.96 vs. TVRRX (-5.21).
TVRRXVIMAXTVRRX / VIMAX
Total Expense Ratio0.870.051,740%
Annual Report Gross Expense Ratio1.900.053,800%
Fund Existence21 years25 years-
Gain YTD10.8019.186118%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets495M214B0%
Annual Yield % from dividends0.001.36-
Returns for 1 year16.8717.0699%
Returns for 3 years49.5451.7196%
Returns for 5 years-5.2136.96-14%
Returns for 10 years76.68159.2848%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTOC0.360.04
+14.10%
Armlogi Holding Corp
STXS1.970.03
+1.55%
Stereotaxis
TREX41.590.03
+0.07%
Trex Company
ADM82.46-0.16
-0.19%
Archer Daniels Midland Company
OLMA10.69-2.02
-15.89%
Olema Pharmaceuticals